Thermo Fisher Scientific (TMO) Q3 2024 Earnings
Thermo Fisher Scientific reported Q3 2024 revenue of $10.6B, missed analyst consensus of $10.6B by $36.6M. Diluted EPS came in at $5.28, beat the $5.25 consensus by $0.03. Thermo Fisher Scientific reports across 4 business segments, led by Life Sciences Solutions, Laboratory Products and Biopharma Services, and Analytical Instruments.
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Thermo Fisher Scientific's Q3 2024 earnings report.
Thermo Fisher Scientific (TMO) reported Q3 2024 earnings on October 23, 2024 before market open.
Thermo Fisher Scientific reported revenue of $10.6B and diluted EPS of $5.28 for Q3 2024.
Revenue missed the consensus estimate of $10.6B by $36.6M. EPS beat the consensus estimate of $5.25 by $0.03.
You can read the 10-Q periodic report (0000097745-24-000046) directly on SEC EDGAR. The filing index links above go to sec.gov.